Pediatric anxiety disorders: Management in primary care

Current Opinion in Pediatrics

Volumn 20, Issue 5, 2008, Pages 538-543

  Sakolsky, Dara ^a   Birmaher, Boris ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Adolescents; Anxiety disorders; Children; Management; Primary care

Indexed keywords

ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; CLOMIPRAMINE; FLUOXETINE; FLUVOXAMINE; IMIPRAMINE; PAROXETINE; PLACEBO; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

ABNORMAL BEHAVIOR; ADOLESCENCE; ANOREXIA; ANXIETY DISORDER; ASTHENIA; BLEEDING; CHILD PSYCHIATRY; CLINICAL TRIAL; COGNITIVE DEFECT; COGNITIVE THERAPY; DECISION MAKING; DIASTOLIC BLOOD PRESSURE; DIFFERENTIAL DIAGNOSIS; EVIDENCE BASED MEDICINE; GENERALIZED ANXIETY DISORDER; HEADACHE; HEALTH CARE MANAGEMENT; HEALTH PRACTITIONER; HUMAN; INSOMNIA; INTERVIEW; MANIA; MENTAL HEALTH; MONITORING; MOTOR ACTIVITY; NAUSEA; PAIN; PATIENT CARE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PULSE RATE; REVIEW; RISK BENEFIT ANALYSIS; SCREENING; SEDATION; SELF REPORT; SEPARATION ANXIETY; SEROTONIN SYNDROME; SIDE EFFECT; SOCIAL PHOBIA; SOMNOLENCE; STOMACH DISCOMFORT; SUICIDAL IDEATION; THERAPY EFFECT;

ADOLESCENT; AGE DISTRIBUTION; ANTI-ANXIETY AGENTS; ANXIETY DISORDERS; CHILD; CHILD, PRESCHOOL; COGNITIVE THERAPY; COMBINED MODALITY THERAPY; FEMALE; HUMANS; MALE; PARENT-CHILD RELATIONS; PEDIATRICS; PHOBIC DISORDERS; PREVALENCE; PRIMARY HEALTH CARE; PROGNOSIS; RISK ASSESSMENT; SEROTONIN UPTAKE INHIBITORS; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; UNITED STATES;

EID: 53549110235     PISSN: 10408703     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOP.0b013e32830fe3fa     Document Type: Review

References (37)

1. American Academy of Child and Adolescent Psychiatry. Practice parameter for the assessment and treatment of children and adolescents with anxiety disorders. J Am Acad Child Adolesc Psychiatry 2007; 46:267-283.
2. Costello EJ, Egger HL, Angold A. Developmental epidemiology of anxiety disorders. In: Ollendick TH, March JS, editors. Phobic and anxiety disorders in children and adolescents: a clinician's guide to effective psychosocial and pharmacological interventions. New York: Oxford University Press; 2004. pp. 61-91.
3. Lewinsohn PM, Gotlib IH, Lewinsohn M, et al. Gender differences in anxiety disorders and anxiety symptoms in adolescents. J Abnorm Psychol 1998; 107:109-117.
4. Messer SC, Beidel DC. Psychosocial correlates of childhood anxiety disorders. J Am Acad Child Adolesc Psychiatry 1994; 33:975-983.
5. Grover RL, Ginsburg GS, lalongo N. Psychosocial outcomes of anxious first graders: a seven-year follow-up. Depress Anxiety 2007; 24:410-420.
6. Buckner JD, Schmidt NB, Lang AR, et al. Specificity of social anxiety disorder as a risk factor for alcohol and cannabis dependence. J Psychiatr Res 2008; 42:230-239.
7. Woodward U, Fergusson DM. Life course outcomes of young people with anxiety disorders in adolescence. J Am Acad Child Adolesc Psychiatry 2001; 40:1086-1093.
8. Alfano CA, Ginsburg GS, Kingery JN. Sleep-related problems among children and adolescents with anxiety disorders. J Am Acad Child Adolesc Psychiatry 2007; 46:224-232.
9. Ginsburg GS, Riddle MA, Davies M. Somatic symptoms in children and adolescents with anxiety disorders. J Am Acad Child Adolesc Psychiatry 2006; 45:1179-1187.
10. Campo JV, Bridge J, Ehmann M, et al. Recurrent abdominal pain, anxiety, and depression in primary care. Pediatrics 2004; 113:817-824.
11. Diagnostic and Statistical Manual of Mental Disorder. 4th ed. (text, revision). Washington, DC: American Psychiatric Association; 2000.
12. Wren FJ, Scholle SH, Heo J, Comer DM. Pediatric mood and anxiety syndromes in primary care: who gets identified? Int J Psychiatry Med 2003; 33:1-16.
13. Horwitz SM, Kelleher KJ, Stein RE, et al. Barriers to the identification and management of psychosocial issues in children and maternal depression. Pediatrics 2007; 119:e208-e218.
14. March JS, Parker JD, Sullivan K, et al. The Multidimensional Anxiety Scale for Children (MASC): factor structure, reliability, and validity. J Am Acad Child Adolesc Psychiatry 1997; 36:554-565.
15. Birmaher B, Khetarpal S, Brent D, et al. The Screen for Child Anxiety Related Emotional Disorders (SCARED): scale construction and psychometric characteristics. J Am Acad Child Adolesc Psychiatry 1997; 36:545-553.
16. Myers K, Winters NC. Ten-year review of rating scales. II: scales for internalizing disorders. J Am Acad Child Adolesc Psychiatry 2002; 41:634-659.
17. Rynn MA, Barber JP, Khalid-Khan S, et al. The psychometric properties of the MASC in a pediatric psychiatric sample. J Anxiety Disord 2006; 20:139-157.
18. Baldwin JS, Dadds MR. Reliability and validity of parent and child versions of the multidimensional anxiety scale for children in community samples. J Am Acad Child Adolesc Psychiatry 2007; 46:252-260.
19. Wren FJ, Bridge JA, Birmaher B. Screening for childhood anxiety symptoms in primary care: integrating child and parent reports. J Am Acad Child Adolesc Psychiatry 2004; 43:1364-1371.
20. Wren FJ, Berg EA, Heiden LA, et al. Childhood anxiety in a diverse primary care population: parent-child reports, ethnicity and SCARED factor structure. J Am Acad Child Adolesc Psychiatry 2007; 46:332-340.
21. Gardner W, Lucas A, Kolko DJ, et al. Comparison of the PSC-17 and alternative mental health screens in an at-risk primary care sample. J Am Acad Child Adolesc Psychiatry 2007; 46:611-618.
22. Silverman W, Albano AM. Manual for the anxiety disorders interview schedule for DMS-IV: child and parent versions. San Antonio, TX: The Psychological Corporation; 1996.
23. Kendall PC, Brady EU, Verduin TL. Comorbidity in childhood anxiety disorders and treatment outcome. J Am Acad Child Adolesc Psychiatry 2001; 40:787-794.
24. Bowen R, Chavira DA, Bailey K, et al. Nature of anxiety comorbid with attention deficit hyperactivity disorder in children from a pediatric primary care setting. Psychiatry Res 2008; 157:201-209.
25. Lewinsohn PM, Zinbarg R, Seeley JR, et al. Lifetime comorbidity among anxiety disorders and between anxiety disorders and other mental disorders in adolescents. J Anxiety Disord 1997; 11:377-394.
26. Wren FJ, Scholle SH, Heo J, Comer DM. How do primary care clinicians manage childhood mood and anxiety syndromes? Int J Psychiatry Med 2005; 35:1-12.
27. Compton SN, March JS, Brent D, et al. Cognitive-behavioral psychotherapy for anxiety and depressive disorders in children and adolescents: an evidencebased medicine review. J Am Acad Child Adolesc Psychiatry 2004; 43:930-959.
28. Compton SN, Piacentini JC, Walkup JT, et al. Child/adolescent anxiety multimodal study (CAMS) : acute phase efficacy and safety results. Presented at the 48th Annual NCDEU Meeting; 29 May 2008; Phoenix.
29. Albano AM, Kendall PC. Cognitive behavioural therapy for children and adolescents with anxiety disorders: clinical research advances. Int Rev Psychiatry 2002; 14:129-134.
30. Kendall PC. Coping cat workbook. Ardmore, PA: Workbook Publishing; 1990.
31. Beidel DC, Turner SM, Sallee FR, et al. SET-C versus fluoxetine in the treatment of childhood social phobia. J Am Acad Child Adolesc Psychiatry 2007; 46:1622-1632.
32. Bridge JA, Iyengar S, Salary CB, et al. Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta-analysis of randomized controlled trials. JAMA 2007; 297:1683-1696.
33. Walkup J, Labellarte M. Complications of SSRI treatment. J Child Adolesc Psychopharmacol 2001; 11:1-4.
34. Rynn MA, Riddle MA, Yeung PP, Kunz NR. Efficacy and safety of extended-release venlafaxine in the treatment of generalized anxiety disorder in children and adolescents: two placebo-controlled trials. Am J Psychiatry 2007; 164:290-300.
35. March JS, Entusah AR, Rynn M, et al. A randomized controlled trial of venlafaxine ER versus placebo in pediatric social anxiety disorder. Biol Psychiatry 2007; 62:1149-1154.
36. Brent D, Emslie G, Clarke G, et al. Switching to another SSRI or to venlafaxine with or without cognitive behavioral therapy for adolescents with SSRI-resistant depression: the TORDIA randomized controlled trial. JAMA 2008; 299:901-913.
37. Walkup JT, March J, Kendall P, et al. Child/adolescent anxiety multimodal study (CAMS); rationale, design and methods. Presented at the 54th Annual Meeting of the American Academy of Child and Adolescent Psychiatry; 23-28 October 2007; Boston.